Cargando…
On the path to 2025: understanding the Alzheimer’s disease continuum
Basic research advances in recent years have furthered our understanding of the natural history of Alzheimer’s disease (AD). It is now recognized that pathophysiological changes begin many years prior to clinical manifestations of disease and the spectrum of AD spans from clinically asymptomatic to...
Autores principales: | Aisen, Paul S., Cummings, Jeffrey, Jack, Clifford R., Morris, John C., Sperling, Reisa, Frölich, Lutz, Jones, Roy W., Dowsett, Sherie A., Matthews, Brandy R., Raskin, Joel, Scheltens, Philip, Dubois, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549378/ https://www.ncbi.nlm.nih.gov/pubmed/28793924 http://dx.doi.org/10.1186/s13195-017-0283-5 |
Ejemplares similares
-
Drug development in Alzheimer’s disease: the path to 2025
por: Cummings, Jeffrey, et al.
Publicado: (2016) -
Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer’s disease
por: Assunção, Sheila Seleri, et al.
Publicado: (2022) -
Virtual Care in CanMEDS 2025
por: Stovel, Rebecca G, et al.
Publicado: (2023) -
Implementing the 2020–2025 Dietary Guidelines for Americans: Recommendations for a Path Forward
por: Sanders, Lisa M, et al.
Publicado: (2021) -
Alzheimer's disease therapeutic research: the path forward
por: Aisen, Paul S
Publicado: (2009)